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The  RE-AIM (Reach  Effectiveness  Adoption  Implementation
Maintenance) planning and evaluation framework has been ap-
plied broadly, but users often have difficulty in applying the mod-
el because of data collection needs across multiple domains and
sources. Questions in the more common “who, what, where, how,
when, and why” format may be an effective guide to ensure that
individual participants, organization staff, and the perspectives of
the  setting  are  considered  in  planning  and evaluation.  Such a
format can also help users in typical community and clinical set-
tings to identify which outcomes are most valued and to focus lim-
ited measurement resources. Translations of RE-AIM that are easy
to understand and apply are needed for application in real-world
community and clinical settings where research and evaluation re-
sources are limited. The purpose of this article is to provide sim-
plified, pragmatic, user-centered and stakeholder-centered recom-
mendations to increase the use of RE-AIM in community and clin-
ical settings and in translational research.
Introduction
The  RE-AIM (Reach  Effectiveness  Adoption  Implementation
Maintenance) framework was first developed to help make re-
search findings more generalizable by encouraging scientists and
evaluators to balance internal and external validity when develop-
ing and testing interventions (1). The goal was to produce pro-
grams and policies with a higher likelihood for uptake and sustain-
ability in typical community or clinical settings. The constitutive
definitions of the RE-AIM dimensions are straightforward and in-
tuitively  appealing  for  community  and  clinical  organizations.
Reach is the number, proportion of the intended audience, and the
representativeness  of  participants  compared with the intended
audience. Effectiveness (or efficacy, depending on the design) is
the degree to which the intervention changes health outcomes and
quality of life, including producing unintended or negative results.
Adoption is the number and proportion of settings and staff mem-
bers that agree to initiate program or policy change and how rep-
resentative they are of the intended audience in terms of the set-
ting and the staff. Implementation is the degree to which those set-
tings and staff members deliver a program or apply a policy as in-
tended, the adaptations made, and the related costs. Finally, main-
tenance is sustained effectiveness at the participant level and sus-
tained (or adapted) delivery at the setting or staff level (1).
The RE-AIM framework encourages planning strategies that can
reach the most people who have health disparities,  effectively
achieve and maintain positive health outcomes, be widely adopted
by diverse settings and staff,  be consistently implemented at a
reasonable cost, and be sustained among varied settings by staff
members with a range of expertise (2). From an evaluative per-
spective, the added focus on representativeness, maintenance, and
organizational level factors provides an opportunity to include, but
also move beyond, considering efficacy or effectiveness as the
only needed indicator of intervention success.
The Diabetes Health Connection, which included interactive tech-
nology  and  health  coach  support  for  patients  with  diabetes,
provides an example of how RE-AIM can be applied to a pro-
grammatic intervention (3). The study documented a 38% partici-
pation rate and that participants were representative of the inten-
ded audience (reach). When compared with a health-risk appraisal
intervention, the effect size was modest but significant and was
positive for primary outcomes and quality of life changes (effect-
iveness). Twenty percent of the clinics approached and 79% of the
staff of those clinics agreed to deliver the intervention, with larger
HMO (health maintenance organization)-affiliated clinics being
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more likely to participate (adoption). The intervention was de-
livered consistently across participating staff members with an im-
plementation rate of nearly 100%, at a cost of $547 per participant
(implementation). Finally, maintenance of effects and organiza-
tional delivery of the intervention were beyond the scope of the
trial but could have been assessed by examining metrics associ-
ated with effectiveness for 6 months or longer, postparticipant
completion of the intervention (individual level maintenance), and
setting-level maintenance based on the sustainability of imple-
mentation metrics.
Although RE-AIM has been applied for varied public health is-
sues and intervention targets, challenges arise when considering
the planning and evaluation of translational projects in typical
clinical or community settings where interventions may be com-
plex and multileveled. Furthermore, primary data collection across
all RE-AIM indicators is challenging given available resources.
For example, some users have reported that doing a “full RE-AIM
application” is overly burdensome or not possible. In such cases, a
pragmatic application of RE-AIM may be warranted (4). We feel
that full use of RE-AIM and going through all of the questions for
planning purposes is possible. However, it is often more challen-
ging for people in community and clinical settings to report res-
ults on all RE-AIM dimensions without research funding.
Even with substantial funding, literature reviews on studies report-
ing use of the RE-AIM framework have generally produced only
incomplete applications of the model. Kessler et al reviewed 42
National Institutes of Health (NIH) grant applications that used the
RE-AIM framework and found that only 10% proposed to address
all 5 RE-AIM dimensions (5). Grants proposed to address between
44% and 78% of the key criteria within a given dimension. In par-
ticular, data on the representativeness of staff members delivering
programs were proposed only 31% of the time. Gaglio et al re-
viewed 71 recent publications, stating that they described use of
the RE-AIM framework, and found that only 44 reported on all
RE-AIM dimensions (6). Within RE-AIM dimensions, reporting
was sparse for data on all elements with setting adoption (eg, per-
centage and representativeness, reasons for declining [0%]; imple-
mentation [2%]; and maintenance [2%]). These data confirm our
observation that, if even these well-funded NIH grants and pub-
lished research studies employed RE-AIM only partially and in-
consistently,  fewer,  well-resourced  community  and  clinical
projects understandably have challenges doing so. Although re-
porting comprehensively on all RE-AIM dimensions can be chal-
lenging,  the RE-AIM model  is  more intuitively appealing and
easier to apply than many alternative evaluation and translation
frameworks. For example, the Greenhalgh (7), the Consolidated
Framework for  Implementation Research (8),  and PRECEDE-
PROCEED models (9) all have considerably more components,
criteria, and measures that may or may not be of direct interest to
clinical and community organizations interested in evaluating the
public health impact of their work.
Purpose
The purpose of this article is to provide and discuss the use of a
series of a familiar set  of “who, what,  when, where,  how, and
why” pragmatic questions based on the RE-AIM framework to
guide the planning and evaluation of intervention strategies (pro-
gram, policy, guideline) when evaluation resources are limited.
We also provide decision points to guide how RE-AIM informa-
tion can be pragmatically gathered and used in planning programs
and evaluating relevant outcomes. Following this, and to make
more concrete pragmatic uses of RE-AIM, we provide example of
pragmatic uses of RE-AIM from the literature (4,10) for both plan-
ning and program evaluation.
We present the key pragmatic planning questions and measuring
suggestions for stakeholders to consider for each RE-AIM dimen-
sion (Table). Users are encouraged to consider these questions
throughout  the  phases  of  planning  and  implementation  — al-
though considering these questions during planning is likely most
useful. During planning, users should consider which dimensions
are most relevant and which they have the resources to measure
well. Users are encouraged to use ongoing evaluation during de-
livery as a method to identify areas where adjustments may be ne-
cessary to achieve the desired outcomes. After program conclu-
sion, follow-up interviews based on the planning questions can be
used effectively to probe and better understand key findings.
Who is (was) intended to benefit and who actually participates or
is exposed to the intervention? This is reach at the level of pa-
tients, clients, or participants. It is important to consider not only
how many persons participate out of those intended or targeted,
but also the characteristics of those who take part compared with
those who do not. Given the impact of health disparities, partici-
pation  levels  of  various  key  underserved  and  vulnerable  sub-
groups are especially important.
What are (were) the most important benefits  you are trying to
achieve and what is (was) the likelihood of negative outcomes?
“What” refers to the effectiveness and individual-level mainten-
ance components of RE-AIM at the patient, client, citizen, or par-
ticipant level. Responses to this question include defining the key
or desired outcomes and the impact on different subgroups (eg,
men vs women; those at high risk vs those at low risk; those with
high incomes or education vs those with low incomes or educa-
tion). Additional outcomes include quality of life indicators and
any negative effects or unintended consequences from the pro-
gram.
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Where is (was) the program or policy applied (and who applied
it)? The issue of participation is also related to the settings level.
Called adoption in the RE-AIM framework, participation is critic-
al to understand the number and types of organizations, clinics, or
agencies that initiate a program or policy. This participation in-
volves considering the characteristics of the settings that are ap-
proached or targeted to participate compared with those that actu-
ally do. It also involves understanding barriers to and facilitators
of adoption as well as how the program or policy fits with organiz-
ational priorities and existing workflow. These issues are also im-
portant at the suborganizational level, particularly in identifying
which staff members try the new compared with those who are
resistant or wait for others to attempt adoption first (11).
How consistently is (was) the program or policy delivered, what
adaptations to the original plans were made, and how much does
(did) it cost? “How” refers to the delivery or implementation of
the intervention. How will the program or policy be delivered,
managed, or enforced? How will you track adaptations or changes
to the program in different settings, by different staff members, or
over time? And how will you ensure that such changes do not re-
duce effectiveness?
How questions also include the organizational resources that are
required and how much the policy or program costs to implement.
Different organizations and decision-makers are concerned about
different types of costs (eg, initial vs ongoing, fixed vs marginal,
personnel vs infrastructure or equipment). Many organizations are
concerned with short-term or medium-term return on investment,
but this often means different things to different people (12). At
minimum, it is important to report the time and staff resources re-
quired so that people in other settings can decide if they have the
resources to adopt a program or policy.
When will (did) the initiative become fully operational, how long
do results last, and how long will (was) the initiative sustained?
“When” refers to organizational, setting, or staff level mainten-
ance. This dimension can be operationalized as the sustainability
of  the  policy  or  program and  includes  consideration  of  many
factors, including but not limited to resource availability; align-
ment of the policy or program with organizational mission, object-
ives, and goals; and integration into job descriptions and perform-
ance evaluations. The timing of results is often important to de-
cision-makers, and the end goal of most policies and programs is
sustainability so that activities become institutionalized or normal-
ized as part of the way of doing business (13).
Why will (did) the results come about? “Why” questions are con-
cerned with the underlying reasons for intervention’s success or
failure and apply across RE-AIM dimensions. Why did they come
about? Often why questions are approached via interviews or oth-
er qualitative approaches, such as focus groups with users, and in
combination with other measures and as ways to probe outcomes
(eg, a program may have little impact because few people particip-
ate; positive effects may be restricted to a subset of users; a pro-
gram can only be implemented successfully by a particular type of
organization or staff person).
Application and Examples
We provide examples of practical application of RE-AIM to is-
sues of planning and outcome evaluation. The “translated,” less
jargon-based RE-AIM questions above may be especially helpful
in comparing 2 or more alternative programs or actions.
Planning application. Finlayson et al provide a helpful illustration
of how RE-AIM can be used to help design a program, in their
case, a program to prevent falls among people with multiple scler-
osis (MS) (4). The International MS Falls Prevention Research
Network used RE-AIM questions to structure initial discussions
with clinicians, people with multiple sclerosis (MS), and repres-
entatives of professional and MS societies about the factors im-
portant to consider in the development of an MS falls-prevention
program for  application in multiple  settings (who and where).
They found a planning tool on the RE-AIM website to be helpful
(http://re-aim.org/re-aim-as-a-planning-tool/). Figure 1 presents a
prototypical example of the graphical summary of results from a
stakeholder  answering  a  series  of  RE-AIM program-planning
questions similar to those presented here. Their group developed a
series of practical questions to ask of a diverse group of people
with MS and health professionals similar to the intended audience
(who). Discussion of these questions, similar to the “who, what,
where, how, when, and why” questions above about each RE-AIM
dimension produced a series of 17 recommendations (what) for
settings that were considering adopting falls prevention programs
in local or regional MS societies (where) to use to plan for suc-
cess. They found that using the RE-AIM framework early in their
work  helped  to  develop  a  feasible  intervention  that  could  be
widely adopted and well implemented and a protocol that maxim-
ized the ability to translate research into practice. Because the Fin-
layson group’s application of RE-AIM was for planning purposes,
they did not  have data on results  (effectiveness),  maintenance
(sustainability), or program costs (implementation). Their use of
the RE-AIM self-rating quiz on the RE-AIM website (www.re-
aim.org) provided initial estimates on most of these issues, but
“why” interviews could have provided additional information for
planning. A score from 1 through 10 is provided for each dimen-
sion, based on the extent to which the various issues within that di-
mension are addressed (Figure 1).
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Figure 1. Summary of the RE-AIM Self-Rating Quiz with a scale for interpreting
scores.
 
Evaluation example. Burke et al used the RE-AIM framework to
evaluate an academic–community partnership approach to address
childhood obesity (10). They identified children aged 8 to 14 years
with a body mass index percentile ranking in the obese range as
those intended to participate and benefit in the Children’s Health
and Activity Modification Program (CHAMP). They also identi-
fied representativeness as the key participation or reach (who) in-
dicator for their feasibility study and documented that the sample
was representative of race, household income, and employment
status when compared with the small regional city where the study
was conducted — while also reporting on the number of parti-
cipants and percentage of the total population that participated
(10).
CHAMP  was  delivered  at  both  university  and  community
(YMCA) locations (ie, Where was the program applied?) and in-
cluded staff from both organizations (10). Twenty-six delivery
personnel participated, all with different levels of expertise but
with experience in providing activities or events for children from
the intended audience. CHAMP focused on weight for child parti-
cipants and demonstrated significant weight reduction that was
maintained for 6 months after the intervention was complete (ie,
What was the benefit and likelihood of maintenance?). The ques-
tion of when the initiative became fully operational and the dura-
tion  of  sustainability  was  not  completely  answerable  in  the
CHAMP project; however, the study documented that of the 26
personnel who were involved in the initial implementation, all
agreed to a second implementation, and additional staff were ad-
ded based on participant feedback (10).
Implementation (How) of the CHAMP intervention strategies was
more than 90%, and assessment of parent comprehension of inter-
vention objectives was used as an indirect assessment of receipt of
intervention components directed at the home (66% of content
correctly identified) (ie, How was the intervention delivered?).
Burke and colleagues also provided information on the cost of im-
plementation across personnel, supplies, and dissemination with a
total of cost of approximately $140,000 across 2 years (ie, How
much did it cost?). Finally, qualitative feedback from participants
indicated that the children found the program engaging and fun to
participate in (Why). Participants also indicated that providing fun
exercise experiences helped distract the children from the intens-
ity of the activities; showing that a variety of healthy food options
helped improve dietary intake; and engagement in the program
helped the children feel better about themselves (all why ques-
tions related to program success) (10).
Discussion
Although RE-AIM is less complex and more intuitive and under-
standable than many evaluation models and systems (6,14), it is
still not easily applied in its full form by community and research
teams (5,15). This article provides a common-sense presentation
of how RE-AIM can be used to address “who, what, where, how,
when, and why” questions important to decision-makers and how
it can be used to plan and evaluate policies and programs. Practic-
al application of selected RE-AIM dimensions can be done by spe-
cifying in advance what impact and outcomes are most important
and by providing a rationale for the dimensions that are and are
not addressed. Such reporting ensures that the pragmatic applica-
tion and use of RE-AIM is justified and not just due to overlook-
ing key issues (16).
These challenges in applying dissemination and evaluation mod-
els in applied or even research settings are not unusual or specific
to RE-AIM. In many ways, this use of RE-AIM for decision-mak-
ing is parallel to environmental impact assessment procedures or
community-informed system dynamics planning (17) in that it can
help ensure that many aspects and different effects, including po-
tential negative and unintended consequences, are considered.
This practical application or translation of RE-AIM can be used to
evaluate different approaches to a given problem or issue and for
various programs, policies, and content areas. Figure 2 provides a
summary example of the application of RE-AIM questions to 2
different programs that compare their results (projected or actual).
This figure addresses the types of issues that environmental plan-
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ners, community policy-makers, public health officials, health care
decision-makers, and comparative-effectiveness researchers have
to make.
Figure  2.  Results  of  comparison of  application  of  RE-AIM questions  to  2
programs. A score of 1 to <5 indicates low application, a score of 5 indicates
medium application,  and a  score  of  >5 to  10 indicates  high  application.
Abbreviation:  RE-AIM,  Reach  Effectiveness  Adoption  Implementation
Maintenance.
 
In summary, the use of who, what, where, how, when, and why
questions based on the RE-AIM model should be useful in both
community and clinical  settings with limited resources.  All  of
these questions and the RE-AIM framework and tools have been
placed in the public domain (www.re-aim.org).  We encourage
their use and hope that in the future there will be sufficient reports
of use of this approach to enable summarizing of results and les-
sons learned from such applications.
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Table
Table. Key Translation and Pragmatic Questions to Consider in Addressing the RE-AIM (Reach Effectiveness Adoption Implementation Maintenance) Dimensions
RE-AIM Dimension Key Pragmatic Questions to Consider and Answera
Reach WHO is (was) intended to benefit and who actually participates or is exposed to the intervention? Measured by number and similarity
of participants to your target group.
Effectiveness WHAT are (were) the most important benefits you are trying to achieve and what is (was) the likelihood of negative outcomes?
Measured by change on key outcome(s) and consistency across subgroups.
Adoption WHERE is (was) the program or policy applied and WHO applied it? Measured by what settings and staff take up the intervention and
which do not.
Implementation HOW consistently is (was) the program or policy delivered, HOW will it be (was it) adapted, HOW much will (did) it cost, and WHY will
(did) the results come about?
Maintenance WHEN will (was) the initiative become operational; how long will (was) it be sustained (setting level); and how long are the results
sustained (individual level)? Measured by longevity of effects (individual level) and program sustainability (setting level).
a Terms in parentheses are phrased for postintervention evaluation. The basic questions are phrased for use in program or policy planning.
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